CA4
GENDER-SPECIFIC PATTERNS OF PRODUCTIVITY LOSS
IN COLORECTAL CANCER SURVIVORS IN A MULTI-
ETHNIC ASIAN POPULATION Swee-Sung Soon National University of Singapore
CU1
COST-UTILITY ANALYSIS OF HERPES ZOSTER VACCINE
IN THAILAND Napha Suranant
Faculty of Pharmaceutical Sciences,
Chulalongkorn University
CU2
COST-EFFECTIVENESS ANALYSIS OF INTERVENTIONS
FOR NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
IN THAILAND Bunchai Chongmelaxme Naresuan University
HM1
IMPACT OF ADOPTION OF A NEW DRUG ON THE
TRENDS IN UTILIZATION PATTERNS CHANGES AND
PHARMACEUTICAL EXPENDITURE- A EXAMPLE OF
URATE-LOWERING THERAPY Yeuh-Lung Peng Kaohsiung Medical University
HM2
MULTIMORBIDITY AND HEALTHCARE SERVICE
UTILIZATION IN THE AUSTRALIAN WORKFORCE:
FINDINGS FROM THE NATIONAL HEALTH SURVEY Lili WANG Menzies Institute for Medical Research
HM4
DERIVATION AND EXTERNAL VALIDATION OF AN
EARLY READMISSION RISK PREDICTION MODEL Sreemanee Raaj Dorajoo National University of Singapore
RM2
DEVELOPMENT, VALIDATION AND PILOT TESTING OF
METABOLIC SYNDROME QUALITY OF LIFE
QUESTIONNAIRE (TAPMETSQOL) Kiranmai Kethireddy
Talla Padmavathi College of Pharmacy,
Warangal, INDIA
RM3
COMPARISON OF CAREGIVER-RATED 3-LEVEL
EUROQOL-5D (EQ-5D-3L) AND HEALTH UTILITIES
INDEX MARK 3 (HUI3) IN PATIENTS WITH DEMENTIA
IN SINGAPORE Vivian Wei Wang National University of Singapore
RM4
RELIABILITY AND VALIDITY OF THE HEALTH
ASSESSMENT QUESTIONNAIRE (HAQ) IN PATIENTS
WITH SPONDYLOARTHRITIS Yu Heng Kwan Duke-NUS Medical School
ISPOR Student Presentations
7th Asia-Pacific Conference
PODIUM SESSION I: MONDAY, 5 SEPTEMBER 2016, 8:30 AM - 9:30 AM
RESEARCH ON METHODS STUDIES
PODIUM SESSION I: MONDAY, 5 SEPTEMBER 2016, 8:30 AM - 9:30 AM
HEALTH CARE EXPENDITURE AND PRICING STUDIES
PODIUM SESSION I: MONDAY, 5 SEPTEMBER 2016, 8:30 AM - 9:30 AM
CANCER OUTCOMES STUDIES
PODIUM SESSION I: MONDAY, 5 SEPTEMBER 2016, 8:30 AM - 9:30 AM
COST UTILITY & QALY STUDIES
CE3
COST-EFFECTIVENESS OF CYP2C19*2 GENOTYPE
GUIDED SELECTION OF CLOPIDOGREL OR
TICAGRELOR IN HONG KONG CHINESE PATIENTS
WITH ACUTE CORONARY SYNDROME Yun Wang The Chinese University of Hong Kong
CE4
THE MULTIDISCIPLINARY RISK ASSESSMENT AND
MANAGEMENT PROGRAM – DIABETES MELLITUS
(RAMP-DM) WAS COST-EFFECTIVE FOR MANAGING
PATIENTS WITH DIABETES MELLITUS Fangfang Jiao The University of Hong Kong
CV1
CAN ACUTE PHASE CLINICAL OUTCOMES PREDICT
HEALTH-RELATED QUALITY OF LIFE AFTER STROKE? Yen Shing Yeoh National University of Singapore
CV2
QUALITY OF LIFE OF STROKE SURVIVORS AND THEIR
INFORMAL CAREGIVERS: A PROSPECTIVE STUDY Enkhzaya Chuluunbaatar National Yang Ming University
CV3
ONGOING ANALYSIS OF CLINICAL AND ECONOMIC
OUTCOMES OF JAPANESE PATIENTS WITH
CORONARY HEART DISEASE UNDERGO
PERCUTANEOUS CORONARY INTERVENTION Ruizhi Zhao University of Minnesota
DB1
DPP-4 INHIBITORS AND CARDIOVASCULAR EVENTS
IN TYPE 2 DIABETIC PATIENTS WITH CHRONIC
KIDNEY DISEASE- A NATIONWIDE COHORT STUDY Tzu-Lan Huang National Taiwan University
DB2
HBA1C VARIABILITY PREDICTS SHORT-TERM RISK OF
ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES Sreemanee Raaj Dorajoo National University of Singapore
DM1
COMMUNITY RESIDENTS' KNOWLEDGE AND
ATTITUDES TOWARDS ANTIBIOTICS IN PENANG,
MALAYSIA: A CROSS-SECTIONAL STUDY Lyna Irawati Universiti Sains Malaysia
DM3
ADHERENCE TO OSTEOPOROSIS DRUGS AND
CLINICAL OUTCOMES AMONG OSTEOPOROSIS
PATIENTS WITH DIFFERENT RISK PROFILES Shih-Tsung Huang
School of Pharmacy, College of Medicine,
National Taiwan University
PODIUM SESSION II: MONDAY, 5 SEPTEMBER 2016, 9:45 AM - 10:45 AM
DISEASE MANAGEMENT STUDIES
PODIUM SESSION II: MONDAY, 5 SEPTEMBER 2016, 9:45 AM - 10:45 AM
DIABETES OUTCOMES STUDIES
PODIUM SESSION II: MONDAY, 5 SEPTEMBER 2016, 9:45 AM - 10:45 AM
CARDIOVASCULAR OUTCOMES STUDIES
PODIUM SESSION II: MONDAY, 5 SEPTEMBER 2016, 9:45 AM - 10:45 AM
COST-EFFECTIVENESS STUDIES
HT3
DIFFERENTIAL PATTERNS OF PERSISTENT OPIOID USE
IN PATIENTS WITH CANCER AND NON-CANCER PAIN Asween Rowena Sani International Islamic University Malaysia
HT4
HUMANISTIC AND ECONOMIC OUTCOMES OF
PHARMACIST-PROVIDED MEDICATION REVIEWS IN
THE ELDERLY: A SYSTEMATIC REVIEW AND META-
ANALYSIS Zhi Wei Ryan Loh National University of Singapore
PGI1
A SYSTEMATIC REVIEW AND META-ANALYSIS ON
TOLERABILITY AND EFFICACY OF SOFOSBUVIR
CONTAINING REGIMENS IN HEPATITIS C PATIENTS
WITH STAGE 4-5 CHRONIC KIDNEY DISEASE Ruchi Singhal
National Institute of Pharmaceutical
Education and Research (NIPER)
PGI10
THE FOLLOW-UP AND UTILIZATION OF DRUG
TREATMENT FOR CHRONIC HBV/HCV PATIENTS
WITH MAJOR PSYCHIATRIC DISEASES IN TAIWAN Chih-Hsiang Tsai Taipei Medical University
PGI12
POLICY EVALUATION ON“THE PAY-FOR-
PERFORMANCE PROGRAM OF HEPATITIS B AND C”
IN TAIWAN Shih-Yin Lu Taipei Medical University
PGI15
KNOWLEDGE, ATTITUDE AND PRACTICE TOWARDS
HEPATITIS B AMONG MEDICAL COLLEGE STUDENTS
OF QUETTA, PAKISTAN Noman ul Haq University of Balochistan
PGI4
COST OF ILLNESS IN DENGUE AND, LIVER DISEASE
PATIENTS OF A RURAL TERTIARY CARE TEACHING
HOSPITAL: A PROSPECTIVE STUDY Gopal teli Gopal teli SACCollege of pharmacy
PHP10
ONLINE PHARMACY REGULATION IN INDIA:A CROSS
SECTIONAL SURVEY ON PERCEPTIONS OF
HEALTHCARE STUDENTS/PROFESSIONALS Peringadi Vayalil Munawar Manipal University
PHP100
A COMPARATIVE ANALYSIS ON HEALTH SECURITY
SYSTEM BETWEEN CHINA AND DEVELOPED
COUNTRIES Jingxian Wu City University of Hong Kong
PHP101
EVALUATION OF ANTIBACTERIAL AND CYTOTOXIC
EFFECTS OF GYMNEMA SYLVESTRE R.BR. SPECIES
CULTIVATED IN PAKISTAN AGAINST COMMON
RESISTANT PATHOGENS Muhammad Tahir
University of Veterinary and Animal Sciences,
Lahore, Pakistan;
PHP102
WHAT IS GOVERNMENT'S RESPONSIBILITY FOR
CHINA'S UNIVERSAL HEALTH SECURITY? AN
OUTLOOK FOR A NATIONAL HEALTH SECURITY
SYSTEM Jingxian Wu Xi'an Jiaotong University
PHP121
PROSPECTIVE STUDY OF THE INCIDENCE, NATURE
AND CAUSES OF DISPENSING ERRORS IN
COMMUNITY PHARMACIES OF ULAANBAATAR,
MONGOLIA Byambatsogt Gendenragchaa
Mongolian National University of Medical
Sciences
POSTER SESSION I: SUNDAY, 4 SEPTEMBER, 12:30 PM - 7:30 PM
HEALTH CARE USE & POLICY STUDIES
POSTER SESSION I: SUNDAY, 4 SEPTEMBER, 12:30 PM - 7:30 PM
GASTROINTESTINAL DISORDERS
PODIUM SESSION II: MONDAY, 5 SEPTEMBER 2016, 9:45 AM - 10:45 AM
HEALTH TECHNOLOGY ASSESSMENT STUDIES
PHP122
THE ACCURACY OF PATIENT SELF REPORT IN
MEASURING CONTINUITY OF CARE IN AUSTRALIA Michael Wright University Technology Sydney
PHP123
MEDICATION RECONCILIATION: A TOOL FOR BETTER
PATIENT CARE Thanmai Vangaveti Manipal College of Pharmaceutical Sciences
PHP131
UNDERSTANDING CONTINUITY OF CARE AT A
PROVIDER AND PRACTICE LEVEL Michael Wright University Technology Sydney
PHP135
A CONCEPTUAL FRAMEWORK OF BASELINE EQUITY
FOR RURAL BASIC MEDICAL INSURANCE IN CHINA:
BASED ON POLICY PROCESS THEORY Jingxian Wu Xi'an Jiaotong University
PHP17
GENERAL PUBLIC KNOWLEDGE AND AWARENESS
ABOUT MEDICINES USE IN PENANG, MALAYSIA Omar Thanoon Dawood Universiti Sains Malaysia
PHP18
QUINOLONES UTILIZATION IN TWO TERTIARY
HOSPITALS IN NIGERIA; A
PHARMACOEPIDEMIOLOGICAL SURVEY Brian Ogbonna NNAMDI AZIKIWE UNIVERSITY
PHP20
DRUG UTILIZATION IN AN OUTPATIENT PRIVATE
PAEDIATRIC SETTING: AN OBSERVATIONAL STUDY Swati Deshwal
National Institute of Pharmaceutical
Education and Research (NIPER)
PHP22
PERLIMINARY STUDY OF MEDICATION REGIMEN
COMPLEXITY AMONG TAIWANESE ELDERLY WHO
HAVE USED ANXIETY OR HYPNOTICS PRESCRIPTIONS Jou-Ying Chen China Medical University
PHP25
ASSOCIATION OF SOCIOECONOMIC CONDITIONS
AND DRUG OFFENCES AND REINCARCERATION Chun-Che Huang National Taiwan University
PHP3
COMPARISION OF PERCEPTION TOWRDS GENERIC
MEDICINES BETWEEN FINAL YEAR PHARMACY AND
MEDICAL STUDENTS IN SOUTHEAST YEMEN Saleh Karamah AL-Tamimi Aden University
PHP35
THE FIRST INDONESIAN HEALTH-RELATED QUALITY
OF LIFE VALUATION STUDY: AN EQ-5D-5L VALUE SET Fredrick Dermawan Purba Erasmus MC
PHP44
RISK OF DISCONTINUATION OF ATMPS CLINICAL
TRIALS Eve Hanna Creativ-Ceutical
PHP45
OUTCOMES FROM HOMEOPATHIC PRESCRIBING IN
SECONDARY CARE HOMEOPATHIC HOSPITAL: A
PROSPECTIVE STUDY Nikunj Dobariya
National Institute of Pharmaceutical
Education and Research (NIPER)
PHP48
WHAT ARE THE KEY CONCERNS OF HEALTH CARE
PROVIDERS IN CHINA? QUALITATIVE INVESTIGATION
OF A DOUBLE-BLIND TELEPHONE SURVEY Yan-kun Sun Peking University
PHP50
EFFECTIVENESS OF TRIGGER TOOLS TO DETECT
ADVERSE DRUG EVENTS FROM DISCHARGE
SUMMARIES: A RETROSPECTIVE STUDY Elstin Anburaj Manipal College of Pharmaceutical Sciences
PHP53
A STUDY ON IDENTIFICATION, MONITORING AND
MANAGEMENT OF ADVERSE DRUG REACTIONS IN A
TERTIARY CARE HOSPITAL Ravikanth Vudugu St.Peter's Institute of Pharmaceutical Sciences
PHP54
CHRONIC PATIENTS ATTITUDES, BELIEFS, AND
EXPERIENCES REGARDING POLYPHARMACY AND
WILLINGNESS TO DEPRESCRIBE IN QUETTA Noman ul Haq University of Balochistan
PHP59
EFFECT OF CLINICAL PHARMACIST IN PATIENT
SAFETY:A PROSPECTIVE INTERVENTIONAL STUDY M Anjillath Nafis Manipal University
PHP60
THE EMERGING ROLES OF PHARMACISTS IN
SELECTED TERTIARY HOSPITALS IN PANGASINAN
AND LA UNION: FOCUS ON PHARMACEUTICAL CARE
AND PHARMACOVIGILANCE Ronald Posadas Cabral Pangasinan State University
PHP63
REFORM OF CHINESE STATE-OWNED ENTERPRISE-
AFFILIATED HOSPITAL Tao Wang Shenyang Pharmaceutical University
PHP74
EVALUATING THE RELATIVE EFFECTIVENESS OF TWO
MALNUTRITION RISK ASSESSMENT TOOLS IN
SURGICAL POPULATION AT A TERTIARY CARE
HOSPITAL IN MALAYSIA Omaid Hayat Khan Universiti Sains Malaysia
PHP78
PREDICTIVE VALIDITY OF NATIONAL NOSOCOMIAL
INFECTION SURVEILLANCE (NNIS) AND STUDY ON
THE EFFICACY OF NOSOCOMIAL INFECTIONS (SENIC)
RISK INDEXES FOR THE INCIDENCE OF SURGICAL SITE
INFECTIONS (SSI) IN GENERAL SURGERY AT HOSPITAL
UNIVERSITI SAINS MALAYSIA ( Omaid Hayat Khan Universiti Sains Malaysia
PHP83
HEALTH RELATED QUALITY OF LIFE FOR DISEASE
POPULATION IN CHINA: A SYSTEMATIC REVIEW Ting Zhou China Pharmacuetical University
PHP89
COMPARISON BETWEEN THE EQ-5D-5L AND THE EQ-
5D-3L FOR GENERAL POPULATION IN CHINA Ting Zhou China Pharmacuetical University
PHP92
ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE
OF HOSPITAL ADMITTED PATIENTS IN TERTIARY
CARE HOSPITALS QUETTA BY USING SF-12
QUESTIONNAIRE Noman ul Haq University of Balochistan
PHP93
EVALUATION OF THE DIFFERENT
PHARMACOECONOMIC MODELS ACROSS THE
WORLD: A COMPARATIVE STUDY Anirudh Kotlo MCOPS Manipal University
PHP95
HOW MUCH ARE CHINESE WILLING TO PAY FOR THE
HEALTH IMPROVEMENT? Jie Sun Shenyang Pharmaceutical University
PMH1
CLINICAL OUTCOMES OF BIPOLAR DISORDER ON
LONG-TERM TREATMENT WITH LITHIUM WITH OR
WITHOUT MOOD STABILIZERS Gerard Q. De Guzman Virgen Milagrosa University Foundation
PMH10
THE ECONOMIC BURDEN OF SCHIZOPHRENIA IN
MALAYSIA Siew Li Teoh Monash University Malaysia
PMH11
ESTIMATED RANGE OF COST OF TREATMENT OF
ADULT SCHIZOPHRENIA PATIENTS AT A TERTIARY
HOSPITAL AS OF OCTOBER 2015 Anthony Tumanan Abala
University of the Philippines-Philippine
General Hospital
PMH12
A COST-EFFECTIVENESS ANALYSIS OF GUANFACINE
EXTENDED-RELEASE TREATMENT IN PEDIATRIC
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER Shuho Maeda Ritsumeikan University
PMH17
ASSESS THE MEDICATION ADHERENCE IN PATIENTS
WITH SEVERE MENTAL ILLNESS ATTENDING PUBLIC
TERTIARY CARE HOSPITALS OF QUETTA, PAKISTAN Noman ul Haq University of Balochistan
PMH2
PREVALENCE AND CHARACTERISTICS OF MENTAL
DISORDERS AMONG HOSPITALIZED BREAST CANCER
PATIENTS IN THE US Xi Wang University of Florida
POSTER SESSION I: SUNDAY, 4 SEPTEMBER, 12:30 PM - 7:30 PM
MENTAL HEALTH
PMH22
ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE
(HRQOL) OF PATIENTS WITH SEVERE MENTAL
ILLNESS ATTENDING TERTIARY CARE PUBLIC
HOSPITALS OF QUETTA, PAKISTAN Noman ul Haq University of Balochistan
PMH26
EXERCISE AND FACTORS INFLUENCE MENTAL
HEALTH OF UNDERGRADUATED STUDENTS AT
BURAPHA UNIVERSITY IN 2014 Chamipa Phanudulkitti Burapha University
PMH9
ECONOMIC BURDEN OF SCHIZOPHRENIA IN CHINA: A
LITERATURE REVIEW Yaozhu Jia Shenyang Pharmaceutical University
PSS11
ANTIMICROBIAL SUSCEPTIBILITY PATTERN IN
CHRONIC SUPPURATIVE OTITIS MEDIA PATIENT IN A
TERTIARY CARE HOSPITAL Akansha Kumar Manipal university
PSS2
SENSITIVITY ANALYSIS OF ANTIBIOTIC COST IN
CHRONIC SUPPURATIVE OTITIS MEDIA PATIENTS IN
SOUTH INDIA: A RETROSPECTIVE OBSERVATIONAL
STUDY Sujeet Kumar Manipal University
PSS3
ANALYSIS OF TWO PRESSURE ULCER DRESSINGS FOR
COST REDUCTION IN THE BRAZILIAN PUBLIC HEALTH
SYSTEM Ana Clara Tolentino
Hospital Universitario Pedro Ernesto -
UERJ/HUPE
PSS4
APPLICATION OF VALUE OF INFORMATION ANALYSIS
TO MINIMIZE DECISION RISK IN MALAYSIA Huey Yi Chong Monash University Malaysia
PSS8
FABRICATION OF ANTI-VITILIGO OINTMENT
CONTAINING PSORALIA CORYLIFOLIA: INVITRO AND
INVIVO CHARACTERIZATION Irshad Hussain SMBB Medical University, Larkana
PSS9
THE EFFECT OF TRADITIONAL MEDICINE ON QUALITY
OF LIFE IN PATIENTS WITH ATOPIC DERMATITIS: A
REVIEW OF RECENT CLINICAL TRIALS Youme Ko Kyung Hee University
PUK10
PATIENT ENGAGEMENT: TO SUPPORT MEDICATION
ADHERENCE IN KIDNEY TRANSPLANTATION Jac Kee Low Monash University
PUK11
LONGITUDINAL TRAJECTORIES OF DEPRESSIVE AND
ANXIOUS SYMPTOMS FOLLOWING A SELF-
MANAGEMENT INTERVENTION FOR HAEMODIALYSIS
PATIENTS Kevin Fu Yuan Lam
Department of Psychology, Faculty of Arts and
Social Sciences, National University of
Singapore
PUK12
PROGRESSION AND OUTCOMES OF NON-DIALYSIS
DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS Yusra Habib Khan Universiti Sains Malaysia
PUK13
QUALITY OF LIFE FOR PATIENTS USING
HEMODIALYSIS (HD) VS. PERITONEAL DIALYSIS (PD)
MODALITIES IN TAIWAN Chao-Hsiun Tang Taipei Medical University
PUK15
MANAGEMENT AND OUTCOMES OF ACUTE KIDNEY
INJURY Anna Asa Suresh Manipal College Of Pharmaceutical Sciences
PUK3
ETIOLOGY AND OUTCOME OF ACUTE KIDNEY INJURY
IN SOUTH INDIAN POPULATION Mohd Zabiuddin Ahad Manipal College of Pharmaceutical Sciences
POSTER SESSION I: SUNDAY, 4 SEPTEMBER, 12:30 PM - 7:30 PM
URINARY/KIDNEY DISORDERS
POSTER SESSION I: SUNDAY, 4 SEPTEMBER, 12:30 PM - 7:30 PM
SENSORY SYSTEMS DISORDERS
PUK5
COMPARATIVE ANALYSIS ON THE OUT-OF-POCKET
EXPENDITURE AMONG PATIENTS SUFFERING FROM
CHRONIC KIDNEY DISEASE BETWEEN MEDICAL
INSURANCE COVERED AND UNCOVERED AREAS IN
CHINA Jingxian Wu Xi'an Jiaotong University
PUK6
PHARMACOECONOMIC EVALUATION OF PATIENTS
UNDERGOING HEMODIALYSIS AT A TERTIARY CARE
CENTRE Srikanth Prasad
Kasturba Medical College Manipal, Manipal
University
PUK7
COST-EFFECTIVENESS OF A COMBINATION OF RENIN-
ANGIOTENSIN SYSTEM INHIBITORS (RAS)/CALCIUM
CHANNEL BLOCKERS (CCB) OR RAS MONOTHERAPY
TO RETARD PROGRESSION OF KIDNEY DISEASE IN
MALAYSIA Nurul Ain Mohd Tahir University of Newcastle
PUK9
PERSISTENCE AND COMPLIANCE WITH NEWLY
INITIATED ANTIHYPERTENSIVE DRUG TREATMENT IN
PATIENTS WITH CHRONIC KIDNEY DISEASE Viet Thanh Truong Laval University
PCV12
USE OF SULFONYLUREAS AND RISK OF
CARDIOVASCUAR DISEASE IN TYPE 2 DIABETIC
WOMEN:A RETROSPECTIVE CASE-CONTROL STUDY Pooja DAS Manipal University
PCV2
RISK OF CARDIOVASCUAR DISEASE IN TYPE 2
DIABETIC WOMEN ON SULFONYLUREAS:A
RETROSPECTIVE CASE-CONTROL STUDY Nithu Johnson manipal college of pharmaceutical sciences
PCV21
HORIZONTAL AND VERTICAL FINANCIAL EQUITY IN
HOSPITALIZED CARDIOVASCULAR PATIENTS; A CASE
STUDY IN IRAN Majid Davari Tehran University of Medical Sciences
PCV23
STROKE TREATMENT COST ANALYSIS FOR
CONSIDERATION ON HEALTH COST DETERMINATION
USING INA-CBG'S (INDONESIA CASE BASED GROUPS)
IN INDONESIA NATIONAL HEALTH INSURANCE
PROGRAMME 2014 Ingenida Hadning Gadjah Mada University
PCV25
COST-EFFECTIVENESS ANALYSIS OF LONG-TERM
VERSUS SHORT-TERM DUAL ANTIPLATELET THERAPY
IN PATIENTS WITH DRUG-ELUTING STENTS Minghuan Jiang The Chinese University of Hong Kong
PCV3
IMPACT OF POTENTIAL DRUG INTERACTIONS IN
CARDIAC PATIENTS ON MORBIDITY RISK: AN
OBSERVATIONAL PROSPECTIVE APPROACH Aymen Fatima St.Peter's Institute of Pharmaceutical Sciences
PCV30
COST EFFECTIVESS ANALYSIS FOR COMBINATION OF
ASPIRIN AND WARFARIN VERSUS WARFARIN ALONE
IN PATIENTS WITH HEART VALVE PROSTHESIS Aya M sharaf Eldin the american university in Cairo
PCV32
A COST-UTILITY ANALYSIS OF DABIGATRAN AND
ENOXAPARIN FOR THROMBOPROPHYLAXIS AFTER
TOTAL HIP OR KNEE REPLACEMENT SURGERY IN
THAILAND Bunchai Chongmelaxme Naresuan University
PCV34
THE OUTCOMES OF A PHARMACEUTICAL CARE
ASSISTANCE PROGRAM IN A ROMANIAN
COMMUNITY PHARMACY Oana Camelia Mic University of Medicine and Pharmacy Craiova
POSTER SESSION II: MONDAY, 5 SEPTEMBER, 8:30 AM - 7:30 PM
CARDIOVASCULAR DISORDERS
PCV38
ASSESSMENT OF UTILITY FOR HEART FAILURE USING
TIME-TRADE OFF(TTO) AND EUROQOL-5
DIMENSION(EQ-5D) IN THE KOREAN GENERAL
POPULATION Jae Yeon Lee School of Pharmacy, Sungkyunkwan university
PCV4
THE IMPACT OF DEMENTIA ON THE OUTCOMES OF
TREATMENTS FOR ACUTE CORONARY SYNDROME Dan Wei Choo National Taiwan University
PCV42
THE USE OF ALHIJAMA AS COMPLIMENTARY
TREATMENT IN HYPERTENSION Inas Ibrahim Universiti Sains Malaysia
PCV43
A REVIEW OF STUDIES OF HEALTH-RELATED QUALITY
OF LIFE PERFORMED IN CHINESE-SPEAKING
ISCHEMIC HEART DISEASE PATIENTS Luan Luan University of Newcastle
PCV47
PRESCRIBING PATTERN OF ANTI HYPERTENSIVE
AGENTS IN A TERTIARY CARE HOSPITAL OUTPATIENT
DEPARTMENT Ashwini Gonthi St.Peter's Institute of Pharmaceutical sciences
PCV49
THE RISKS OF USING CHINESE MEDICATIONS
ASSOCIATED WITH CARDIOVASCULAR DISEASE,
DIABETES MELLITUS, AND CHRONIC KIDNEY DISEASE-
A SYSTEMATIC REVIEW Yu-Shan Wang China Medical University
PCV5
ACCELERATED/MALIGNANT HYPERTENSION WITH A
DIAGNOSTIC AMBUGITY: A RETROSPECTIVE COHORT
STUDY Marupuru Srujitha manipal university
PCV56
PRESCRIPTION TREND IN ANTIHYPERTENSIVE DRUGS
IN MUMBAI AND SUBURBS: A SURVEY Gauri Vijay Desai BOMBAY COLLEGE OF PHARMACY
PCV6
ASSESSMENT OF SECONDARY RECURRENCE OF
STROKE IN ASPIRIN-CLOPIDOGREL COMBINATION
THERAPY AND ASPIRIN MONOTHERAPY IN
TRANSIENT ISCHEMIC ATTACK PATIENTS IN SOUTH
INDIA: A COMPARATIVE STUDY Mriganka Pal St.Peter's Institute of Pharmaceutical Sciences
PMD10
SCREENING RATE FOR DIABETIC RETINOPATHY AND
MACULAR EDEMA IN PATIENTS WITH DIABETES AND
THEIR TREATMENT COSTS IN THE UNITED ARAB
EMIRATES Seyung-He Je Chung-Ang University
PMD11
TELEDERMOSCOPY AS A REFERAL METHOD IN
AUSTRALIA: A COST ANALYSIS USING DECISION
MODELLING Centaine Snoswell The University of Queensland
PMD3
DIAGNOSTIC ACCURACY OF ASSESSMENT METHODS
FOR DIAGNOSING DIABETIC PERIPHERAL
NEUROPATHY (DPN): A SYSTEMATIC REVIEW AND
META-ANALYSIS: AN EVIDENCE BASED APPROACH Venkata Murali Krishna Gangavarapu NIPER Mohali
PMD4
CLINICAL AND ECONOMIC IMPACT OF BLOOD
CULTURES AMONG ADULT PATIENTS ADMITTED
WITH PNEUMONIA IN TIANJIN, CHINA Ning Yu Tianjin University
PMD5
AN OBSERVATIONAL STUDY ON RISK FACTORS AND
CLINICAL PRESENTATION S IN STROKE PATIENTS Dharani Gopu St.peter's Institute of Pharmaceutical Sciences
PMD7
SUBATMOSPHERIC PRESSURE THERAPY EFFICIENCY
FOR THE TREATMENT OF PRESSURE ULCERS: A
HEALTH TECHONOLOGY ASSESSMENT Ana Clara Tolentino
HUPE/UERJ Universidade do Estado do Rio de
Janeiro
POSTER SESSION II: MONDAY, 5 SEPTEMBER, 8:30 AM - 7:30 PM
MEDICAL DEVICES/DIAGNOSTICS
PMD8
A CLINICAL LITERATURE REVIEW OF CORONARY
ARTERY CALCIFICATION AND CURRENT TREATMENT
OUTCOMES IN JAPAN Ruizhi Zhao University of Minnesota
PND10
COST-EFFECTIVENESS OF POPULATION SCREENING
FOR HAEMOCHROMATOSIS IN AUSTRALIA: A STATE-
TRANSITION MODEL Barbara L. de Graaff Menzies Institute for Medical Research
PND11
COST-EFFECTIVENESS OF NEWER ANTIEPILEPTIC
DRUGS (AEDS) FOR MANAGEMENT OF PARTIAL
EPILEPSY IN CHILDREN IN MALAYSIA Nurul Ain Mohd Tahir University of Newcastle
PND12
ADHERENCE, HEALTHCARE RESOURCE UTILIZATION
AND DIRECT MEDICAL COSTS AMONG PATIENTS
WITH ALZHEIMER'S DISEASE IN TIANJIN, CHINA Shitong Xie Tianjin University
PND15
COST-EFFECTIVENESS ANALYSIS OF NON-INVASIVE
PRENATAL TESTING FOR DOWN'S SYNDROME IN
CHINA Yan Xu Fudan University
PND9
AN AUSTRALIAN NATIONAL COST OF ILLNESS STUDY
FOR HEREDITARY HAEMOCHROMATOSIS Barbara L. de Graaff Menzies Institute for Medical Research
PRM1
HEPATITIS B VACCINATION IN DIALYSIS PATIENTS. IS
IT REALLY PROTECTIVE? Sindhu Kaza
Kasturba Medical College Manipal, Manipal
University
PRM11
A SYSTEMATIC REVIEW ON METHODOLOGICAL
HETEROGENEITY IN ESTIMATING PRODUCTIVITY
LOSS ASSOCIATED WITH COLORECTAL CANCER Kathryn Harsono National University of Singapore
PRM16
MAPPING OF EXISTING DATA SOURCES FOR THE
CONDUCT OF REAL-WORLD STUDIES ON LUNG
CANCER IN CHINA Chung Yan Yuen Faculty of Pharmacy, Université de Montréal
PRM22
VALIDATION OF MODEL-SIMULATED CLINICAL
OUTCOMES OF ANTIPLATELET THERAPIES IN
PATIENTS WITH ACUTE CORONARY SYNDROME Minghuan Jiang The Chinese University of Hong Kong
PRM25
VARIATION OF DATA SOURCE USED FOR BASELINE
POPULATION AND FOR NATURAL COURSE OF
ALZHEIMER'S DISEASE PROGRESSION IN MODEL-
BASED ECONOMIC EVALUATION OF TREATMENT OF
AD Verin Lerjanyakun Kyoto University
PRM29
ON A DESIGN ISSUE OF EQ-5D-3L VALUATION
STUDIES: SHOULD LIKELIHOOD OF THE HEALTH
STATES BE CONSIDERED? Zhihao Yang Erasmus University Rotterdam
PRM30
RELIABILITY AND VALIDITY OF THE SHORT-FORM 36
(SF-36) HEALTH SURVEY IN PATIENTS WITH
SPONDYLOARTHRITIS Yu Heng Kwan Duke-NUS Medical School
PRM31
A COMPARISON OF EUROQOL EQ-5D AND SF-36 FOR
ESTIMATING HEALTH-ADJUSTED LIFE-EXPECTANCY
(HALE) IN TAIWAN Chih-Hsien Liao National Taiwan University
PRM32
PSYCHOMETRIC PROPERTIES AND MEASUREMENT
EQUIVALENCE OF THE ENGLISH AND CHINESE
VERSIONS OF THE BECK ANXIETY INVENTORY IN
PATIENTS WITH BREAST CANCER Terence Ng National University of Singapore
POSTER SESSION II: MONDAY, 5 SEPTEMBER, 8:30 AM - 7:30 PM
RESEARCH ON METHODS
POSTER SESSION II: MONDAY, 5 SEPTEMBER, 8:30 AM - 7:30 PM
NEUROLOGICAL DISORDERS
PRM36
PREFERENCE INVERSION AND INDIVIDUAL
CHARACTERISTICS John D. Hartman Moffitt Cancer Center
PRM46
A CALCULATING ANALYSIS MODEL ON DISABILITY
ADJUSTED OF LIFE YEARS AMONG PATIENTS
SUFFERING FROM ALZHEIMER'S: BASED ON THE
IMPROVEMENT OF MULTI-STATE MARKOV MODEL Jingxian Wu Xi'an Jiaotong University
PRM47
ANTIVIRAL ACTIVITY AND EMBRYONIC TOXICITY OF
MOXIDECTIN AGAINST INFLUENZA VIRUS H9 Rabia Hameed
University of Veterinary & Animal Sciences
Lahore, Pakistan
PRM5
TO EVALUATE THE OUTCOMES OF CONCOMITANT
CHEMORADIOTHERAPY FOLLOWED BY EXTENDED
ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH
NEWLY DIAGNOSED GLIOBLASTOMA - A
RETROSPECTIVE STUDY Surbhi Gupta
Delhi Institute of Pharmaceutical Sciences and
Research
PRM8
EMPIRICAL CALIBRATION OF HEPATITIS C VIRUS
(HCV) NATURAL HISTORY MODEL TO THE CHINESE
HCV-INFECTED POPULATION Kyueun Lee Stanford University
PRS16
COMPARATIVE EFFECTIVENESS ANALYSIS FOR
SMOKING CESSATION MEDICATIONS Hui-Chin Chang
Institute of Health and Welfare Policy,
National Yang-Ming University
PRS17
COMPARATIVE EFFECTIVENESS ANALYSIS FOR
SMOKING CESSATION MEDICATIONS AND RELAPSE I-Ting Wang National Yang Ming University
PRS19
DRUG UTILIZATION EVALUATION STUDY OF
SILDENAFIL IN A TERTIARY CARE TEACHING
HOSPITAL IN INDIA – A RETROSPECTIVE ANALYSIS Reshma Susan Reji Manipal University
PRS20
ANTIASTHMATIC DRUG PRESCRIBING PATTERN
ASSESSMENT AT MEDICAL REIMBURSEMENT IN
EMPLOYEES HEALTH CARE FACILITY OF BANARAS
HINDU UNIVERSITY Dev Priya INSTITUTE OF MEDICAL SCIENCES
PRS21
INHALED ILOPROST THERAPY AND PULMONARY
ARTERIAL HYPERTENSION: EXPERIENCE IN A
FORMULARY DECISION STUDY Leroy Koh Nova Southeastern University
PRS4
VALIDATION OF A NOVEL TOOL TO PREDICT
OUTCOMES IN PATIENTS WITH NOSOCOMIAL
PNEUMONIA Meenakshi Srinivasan
Manipal College of Pharmaceutical Sciences,
Manipal University
PRS6
COMPARISON OF HEALTHCARE UTILIZATION AND
COST DEPENDING ON THE SEVERITY OF ASTHMA:
ANALYSIS OF THE KOREAN NATIONAL HEALTH
INSURANCE CLAIMS DATABASE Yoo Ju Lee School of Pharmacy, Sungkyunkwan University
POSTER SESSION II: MONDAY, 5 SEPTEMBER, 8:30 AM - 7:30 PM
RESPIRATORY-RELATED DISORDERS
PSY11
COST ASSESSMENT OF IMPLEMENTATION OF
IMMUNE TOLERANCE INDUCTION IN KMC HOSPITAL Benson Babu Manipal University
PSY15
A UNIQUE OPPORTUNITY TO ASSESS QUALITY OF
LIFE CHANGES IN LONG-TERM WAITLISTED
BARIATRIC SURGERY PATIENTS USING THE EQ-5D-5L
AND AQOL-8D MULTI-ATTRIBUTE UTILITY
INSTRUMENTS BEFORE AND THREE MONTHS AFTER
BARIATRIC SURGERY: AN EXPLORATORY STUDY Julie A. Campbell University of Tasmania
PSY16
PERCEPTIONS OF THALASSEMIA PATIENTS' ON
THALASSEMIA AND ITS TREATMENT: A QUALITATIVE
EXPLORATION wan Ismahanisa Ismail
Faculty of Health Sciences University
Technology MARA
PSY20
COMPARE POLICIES AND RESEARCH SITUATION OF
RARE DISEASES AND ORPHAN DRUGS BETWEEN
CHINA AND OTHER COUNTRIES Tongtong Li Shenyang Pharmaceutical University
PSY21
REAL-WORLD COMPARING INTRAVENOUS
BUSULFAN TO TOTAL BODY IRRADIATION IN
HEMATOPOIETIC STEM CELL TRANSPLANTATION
WITH A JAPANESE DIAGNOSIS PROCEDURE
COMBINATION (DPC) DATABASE Mihoko Ota
Tokyo Medical and Dental University
Graduate School of Medicine
PSY26
COMPLEMENTARY AND ALTERNATIVE MEDICINE
(CAM) DISCLOSURE TO THE HEALTH CARE
PROVIDERS: A QUALITATIVE INSIGHT FROM
MALAYSIA THALASSEMIA PATIENTS wan Ismahanisa Ismail
Faculty of Health Sciences University
Technology MARA
PSY6
PREVALENCE AND MANAGEMENT OF ANEMIA IN
PATIENTS OF CHRONIC KIDNEY DISEASE AT A
TERTIARY CARE PUBLIC TEACHING HOSPITAL:
EVIDENCE FROM A CROSS SECTIONAL STUDY Rajiv Ahlawat
National Institute of Pharmaceutical
Education and Research (NIPER)
PSY9
COST BURDEN OF CROHN'S DISEASE AND
ULCERATIVE COLITIS IN THE UNITED STATES Chao Chen University of Florida
PCN1
CHEMOTHERAPY, CYTOKINES AND CANCER-RELATED
FATIGUE: A SYSTEMATIC REVIEW OF QUANTITATIVE
STUDIES IN 1312 PATIENTS Tewodros Eyob Woldehaimanot National University of Singapore
PCN14
LITERATURE REVIEW ON HOSPITAL COSTS FOR
PATIENTS UNDERGOING GASTRECTOMY Brian Po-Han Chen Ethicon Inc.
PCN2
PREVALENCE OF COMORBIDITIES AND HEALTH
STATUS AMONG CURRENT CANCER AND CANCER
SURVIVORS: AN AUSTRALIAN POPULATION-BASED
STUDY Huah Shin Ng University of South Australia
PCN20
PHARMACOECONOMIC EVALUATION OF CANCER
TREATMENTS IN INDIA Shilpa Sundar Manipal University
PCN29
OPTIMAL AND ENSURE TRIALS - BASED COMBINED
COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB
VERSUS CHEMOTHERAPY FOR THE FIRST- LINE
TREATMENT OF ASIAN PATIENTS WITH
NONSQUAMOUS NON– SMALL-CELL LUNG CANCER Feng Wen West China Hospital, Sichuan University
POSTER SESSION III: TUESDAY, 6 SEPTEMBER, 8:30 AM - 3:00 PM
CANCER
POSTER SESSION II: MONDAY, 5 SEPTEMBER, 8:30 AM - 7:30 PM
SYSTEMIC DISORDERS/CONDITIONS
PCN3
A MODIFICATION OF CURRENT PRIMARY SCREENING
PROTOCOL FOR COLORECTAL CANCER IN CHINA Ye Ding Zhejiang University
PCN33
COST EFFECTIVENESS OF BRCA MUTATION TESTING
FOR EARLY-STAGE BREAST CANCER PATIENTS WITH
FAMILY HISTORY IN MALAYSIA Ka Keat Lim Duke NUS Medical School
PCN43
DESIGNING A DISCRETE CHOICE EXPERIMENT TO
MEASURE PATIENT PREFERENCES AND WILLINGNESS-
TO-PAY FOR TARGETED THERAPIES FOR COLORECTAL
CANCER IN SINGAPORE Xin Yi Wong National University of Singapore
PCN48
THE IMPACT OF CANCER PREVENTION AND
TREATMENT POLICY ON INCREASING INCIDENCE OF
EARLY-STAGE CANCER IN TAIWAN Chao-Hsiun Tang Taipei Medical University
PCN50
COMPARISON OF THE TRENDS OF ORPHAN DRUGS
DESIGNATIONS AND APPROVALS IN THE UNITED
STATES AND EUROPE IN ONCOLOGY Eve Hanna Creativ-Ceutical
PCN51
CURRENT PRACTICE AND ATTITUDE REGARDING OFF-
LABEL DRUG USE: A SURVEY OF ONCOLOGY
PRACTITIONERS Mohammad Masnoon Saiyed National University of Singapore
PCN53
ACCESS TO ANTI-CANCER DRUGS IN INDIA: IS THERE
A NEED TO REVISE REIMBURSEMENT POLICIES? Gertruud Haitsma University of Groningen
PCN8
PREVALENCE OF SHISHA SMOKING AMONG ADULT
MALE CIGARETTE SMOKERS OF MULTAN, PAKISTAN Muhammad Majid Aziz
Xi'an Jiaotong University, Xi'an, Shaanxi, P. R.
China
PDB10
PRESENCE OF LIPOHYPERTROPHY AND ITS RELATION
TO INSULIN INJECTION PRACTICES IN PATIENTS WITH
TYPE 1 DIABETES MELLITUS Anjana Barola
National Institute of Pharmaceutical
Education and Research (NIPER)
PDB16
FACTORS ASSOCIATED WITH GLYCEMIC CONTROL
AND DIABETES-RELATED COSTS IN PATIENTS WITH
DIABETES IN THE UNITED ARAB EMIRATES: RESULTS
FROM A RETROSPECTIVE LARGE CLAIMS DATA
ANALYSIS Yong Chan CHOI Chung-Ang University
PDB18
COST-EFFECTIVENESS OF DAPAGLIFLOZIN VERSUS
ACARBOSE AS A MONOTHERAPY IN TYPE 2 DIABETES
IN CHINA Shuyan Gu Zhejiang University
PDB2
PROTECTIVE EFFECT OF METFORMIN AGAINST
TUBERCULOSIS IN DIABETIC PATIENTS Swathi P MCOPS, Manipal University
PDB20
COST-EFFECTIVENESS OF INSULIN DEGLUDEC
TREATMENT IN PATIENTS WITH TYPE1 AND TYPE 2
DIABETES MELLITUS: A SYSTEMATIC REVIEW Xiaomeng Yue University of Cincinnati
PDB23
A STUDY ON COMPARATIVE EFFICACY AND COST
EFFECTIVENESS OF PREGABALIN AND DULOXETINE
USED IN DIABETIC NEUROPATHIC PAIN Midhun K. Roy National College of Pharmacy
POSTER SESSION III: TUESDAY, 6 SEPTEMBER, 8:30 AM - 3:00 PM
DIABETES/ENDOCRINE DISORDERS
PDB29
STUDY ON MEDICATION ADHERENCE BEHAVIOR AND
QUALITY OF LIFE IN ELDERLY DIABETC,
HYPERTENSION PATIENTS IN A TERTIARY CARE
HOSPITAL; A PROSPECTIVE STUDY Ramanath katta Venkatesh MCOPS,Manipal University
PDB33
ASSESSMENT OF KNOWLEDGE AND PRACTICE
REGARDING FOOT CARE OF DIABETES MELLITUS
PATIENT IN TERTIARY CARE HOSPITALS, QUETTA,
PAKISTAN Noman ul Haq University of Balochistan
PDB36
TRANSLATION, ADAPTATION AND VALIDATION OF
THE DIABETES DISTRESS SCALE FOR INDONESIAN
DIABETIC OUTPATIENTS WITH VARIOUS TYPES OF
COMPLICATIONS Bustanul Arifin University of Groningen the Netherlands
PDB37
AN OBSERVATIONAL STUDY ON HELATH RELATED
QUALITY OF LIFE IN DIABETES MELLITUS PATIENTS Prathyusha rani Thunla St.peter's institute of pharmaceuticals sciences
PDB38
PSYCHOMETRIC PROPERTIES OF THE CHINESE
VERSION OF PROBLEM AREAS IN DIABETES SCALE
(SG-PAID-C) AMONG HIGH-RISK POLYPHARMACY
PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES IN
SINGAPORE Melanie Siaw National University of Singapore
PDB42
HEALTHCARE DIRECT COST BURDEN OF DIABETES IN
MEDICARE BENEFICIARIES WITH OBESITY Rashi Jaiswal University of the Sciences, Philadelphia
PDB9
NEED FOR ENHANCED GLUCOSE SCREENING IN
PREGNANT WOMEN IN INDONESIA Najmiatul Fitria University of Groningen
PIH13
THE GUARDIANS' CHOICES AND PREFERENCES FOR
IMPORTED SURROGATE VACCINES IN CHINA: BASED
ON A SURVEY IN SHENYANG, LIAONING PROVINCE Yawei Hao Shenyang Pharmaceutical University
PIH15
USING A DISCRETE CHOICE EXPERIMENT TO VALUE
INFORMAL CARE PROVIDED TO CHILDREN WITH
INTELLECTUAL DISABILITIES Sheena Arora University of Technology Sydney
PIH17
CHANGING PATTERNS OF MEDICATION USE AT THE
END OF LIFE IN THE ELDERLY Hsien-Yei Chuang
Graduate Institute of Clinical Pharmacy,
College of Medicine, National Taiwan
University
PIH19
THE EFFECT OF REDUCING COST-SHARING FOR
CHILDREN ON UTILIZATION OF INPATIENT SERVICES:
EVIDENCE FROM JAPAN Hirotaka Kato Kyoto University
PIH20
HOW DID THE PAST AFFECT THE PRESENT: SOCIAL
PREDICTORS OF AMBULATORY CARE UTILIZATION
AMONG THE ELDERLY Ka Keat Lim Duke NUS Medical School
PIH23
HOUSEHOLD COST OF INJURIES IN CHILDREN UNDER
FIVE YEARS IN THE EJISU-JUABENG MUNICIPALITY OF
THE ASHANTI REGION, GHANA: A CROSS SECTIONAL
STUDY John Amissah
Kwame Nkrumah University of Science and
Technology
PIH24
TRADITIONAL AND COMPLEMENTARY MEDICINE USE
AMONG WOMEN TO CONCEIVE AND DURING
PREGNANCY: A LITERATURE REVIEW Maryam Farooqui Universiti Teknologi MARA (Bertam campus)
POSTER SESSION III: TUESDAY, 6 SEPTEMBER, 8:30 AM - 3:00 PM
INDIVIDUAL'S HEALTH
PIH25
CLINICAL AND ECONOMIC OUTCOMES OF
PHARMACIST-PROVIDED HOME-BASED MEDICATION
REVIEW IN THE ELDERLY: A SYSTEMATIC REVIEW
AND META-ANALYSIS Shu Ying Tan National University of Singapore
PIH26
ASSOCIATION BETWEEN SUBJECTIVE WELL-BEING
AND HEALTH STATUS AMONG THE ELDERLY IN
CHINA: THE INFLUENCES OF SOCIAL SUPPORT AND
SOCIAL ADJUSTMENT Chengzhen Bao Zhejiang University
PIH4
PREVALENCE OF LOW BIRTHWEIGHT AND ITS
CORRELATES FROM 2008 TO 2014 IN XINDU COUNTY
OF CHENGDU, CHINA Ping Zhu Sichuan University
PIN1
EVALUATION OF POTENTIAL DRUG-DRUG
INTERACTIONS AMONG THE PEOPLE LIVING WITH
HIV WITH HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
AT KASTURBA HOSPITAL Kavyasri Immadisetti Manipal University
PIN10
ASSESSING THE BROADER ECONOMIC
CONSEQUENCES OF HPV PREVENTION IN INDONESIA
USING A GOVERNMENT PERSPECTIVE FISCAL
ANALYTIC METHOD Didik Setiawan University of Groningen
PIN11
ROLE OF TIERED PRICING POLICY IN IMPROVING
ACCESS TO MEDICINES IN INDIA Prashant Soni
Delhi Institute of Pharmaceutical Sciences &
Research
PIN13
COST-EFFECTIVENESS ANALYSIS OF LEVOFLOXACIN
750MG DURING 5 DAYS VERSUS LEVOFLOXACIN
500MG DURING 10 DAYS FOR THE TREATMENT OF
COMUNITY-ACQUIRED PNEUMONIA UNDER THE
BRAZILIAN PUBLIC HOSPITAL PERSPECTIVE Ana Clara Tolentino
Hospital Universitario Pedro Ernesto -
UERJ/HUPE
PIN14
DIRECT MEDICAL COSTS OF HCV PATIENTS USING
NATIONAL HEALTH INSURANCE CLAIMS DATA IN
SOUTH KOREA Daewon Kang Korea University
PIN17
TREATMENT PATTERN OF ANTIBIOTICS AND COST
ANALYSIS IN SEPSIS PATIENTS: A CROSS SECTIONAL
RETROSPECTIVE & PROSPECTIVE STUDY Maneesha Erraboina St.Peter's Institute of Pharmaceutical Sciences
PIN18
ECONOMIC BURDEN OF COMMUNITY-ACQUIRED
PNEUMONIA AMONG ELDERLY Keiko Konomura Meiji Pharmaceutical University
PIN19
CRITICAL ISSUES INFLUENCING COST-EFFECTIVENESS
ANALYSES OF PNEUMOCOCCAL VACCINE STRATEGY
FOR ELDERLY IN JAPAN Yuki Takumoto Meiji Pharmaceutical University
PIN20
COST-EFFECTIVENESS ANALYSIS OF CASPOFUNGIN
VS. VORICONAZOLE IN THE EMPIRICAL ANTIFUNGAL
THERAPY OF FEBRILE NEUTROPENIA IN CHINA Yan Wei Fudan University
PIN21
A PARALLEL OBSERVATIONAL AND PROSPECTIVE
STUDY ON PHARMACOECONOMIC ANALYSIS AND
PRESCRIBING PATTERN OF ANTIBIOTICS IN
INFECTIOUS DISEASES Chaitra Chenna St peter's Institute of Pharmaceutical sciences
PIN22
ECONOMIC EVALUATIONS OF HAEMOPHILUS
INFLUENZAE TYPE B VACCINE: A SYSTEMATIC REVIEW Bunchai Chongmelaxme Naresuan University
POSTER SESSION III: TUESDAY, 6 SEPTEMBER, 8:30 AM - 3:00 PM
INFECTION
PIN25
COST-EFFECTIVENESS OF GRANULOCYTE COLONY-
STIMULATING FACTOR (G-CSF) AS ADJUNCTIVE
THERAPY IN CANCER PATIENTS WITH ESTABLISHED
FEBRILE NEUTROPENIA Xiao Jun Wang National University of Singapore
PIN27
COST-UTILITY ANALYSIS OF ATAZANAVIR/RITONAVIR
200/100 MG VERSUS ATAZANAVIR/RITONAVIR
300/100 MG IN THAI ADULTS WITH VIROLOGIC
SUPPRESSION Naliya Maneesawangwong
Faculty of Pharmaceutical Sciences,
Chulalongkorn University
PIN30
ROLE OF TUBERCULOSIS HOME OBSERVER IN
IMPROVING CLINICAL OUTCOME OF PATIENT IN
YEMEN AMMAR ALI Saleh Jaber Universiti Sains Malaysia
PIN31
ANTIMICROBIAL AGENTS DISPENSING IN UPPER
RESPIRATORY TRACT, GASTROINTESTINAL TRACT
INFECTIONS AND INFECTED WOUND IN THAI DRUG
STORES IN 2015 Pintip Pongpech Chulalongkorn University
PIN33
THE PUBLIC ACCEPTANCE AND WILLINGNESS-TO-PAY
(WTP) OF DENGUE VACCINE IN PENANG, MALAYSIA:
ASSESSMENT WITH A CONTINGENT VALUATION
STUDY Hui Yee Yeo Universiti Sains Malaysia
PIN37
COMMUNITY RESIDENTS' KNOWLEDGE AND
PERCEPTIONS OF ANTIBIOTIC RESISTANCE IN
PENANG, MALAYSIA: FINDINGS AND IMPLICATIONS Lyna Irawati Universiti Sains Malaysia
PIN8
DETERMINATION OF PREDICTORS OF PROLONGED
HOSPITALIZATION AMONG DENGUE PATIENTS
ATTENDING TERTIARY CARE HOSPITAL IN MALAYSIA Tauqeer Hussain Mallhi University Sains Malaysia
PIN9
A STUDY ON EVALUATION OF EFFECTS OF ANTI-
TUBERCULAR DRUGS ON HEMATOLOGICAL AND
HEPATO-RENAL FUNCTIONS IN TUBERCULOSIS
PATIENTS Sharon Vidya Sagar St.Peter's Institute of Pharmaceutical Sciences
PMS10
EVALUATE THE COST-EFFECTIVE THRESHOLD OF
OSTEOPOROSIS TREATMENT ON ELDERLY WOMEN
IN CHINA USING DISCRETE EVENT SIMULATION
MODEL Weiyi Ni University of Southern California
PMS11
COST-EFFECTIVENESS OF BISPHOSPHONATES FOR
PRIMARY AND SECONDARY PREVENTION OF HIP-
RELATED FRACTURE WITH GLUCOCORTICOID-
INDUCED OSTEOPOROSIS IN MALAYSIA Nurul Ain Mohd Tahir University of Newcastle
PMS15
PSYCHOLOGICAL DISTRESS IN CHINESE PATIENTS
WITH RHEUMATOID ARTHRITIS AND PSYCHOMETRIC
VALIDATION OF CHINESE HOSPITAL ANXIETY AND
DEPRESSION SCALE Hao Hu University of Newcastle
PMS18
TREATMENT GAP OF POST OSTEOPOROTIC
FRACTURES IN TAIWAN: A NATIONWIDE COHORT
STUDY, 2008-2013 Chen-Yu Wang
School of Pharmacy, College of Medicine,
National Taiwan University
PMS2
CLINICAL EVALUATION OF AMRITHA GUGGULU IN
THE MANAGEMENT OF GOUT Hariprasad Kuvettu
Muniyal Institute Of Ayurveda Medical
Sciences, Manipal.
PMS21
MAPPING THE PRESCRIPTION TREND FOR
RHEUMATOID ARTHRITIS IN MUMBAI, INDIA Abhishek Sanjay Kulkarni Bombay College of Pharmacy
POSTER SESSION III: TUESDAY, 6 SEPTEMBER, 8:30 AM - 3:00 PM
MUSCULAR-SKELETAL DISORDERS
PMS5
RISK AND BURDEN OF SUBSEQUENT FRACTURES
AFTER FIRST OSTEOPOROSIS-RELATED FRACTURE
AMONG OSTEOPOROSIS PATIENTS IN TIANJIN, CHINA Ke Wang Lilly Suzhou Pharmaceutical Company, Ltd.
PMS6
BURDEN OF OSTEOPOROSIS-RELATED HIP FRACTURE
IN ASIA. A REVIEW OF HEALTHCARE COSTS AND
RESOURCE UTILIZATION Nurul Ain Mohd Tahir University of Newcastle